Interleukin-1: A key inflammatory mediator in psoriasis?

被引:64
|
作者
Mee, JB
Cork, MJ
di Giovine, FS
Duff, GW
Groves, RW
机构
[1] Univ London Kings Coll, St Thomas Hosp, St Johns Inst Dermatol, London SE1 7EH, England
[2] Univ Sheffield, Div Genom, Sheffield S10 2TN, S Yorkshire, England
关键词
IL-1; keratinocyte; psoriasis;
D O I
10.1016/j.cyto.2005.12.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pro-inflammatory cytokine interleukin-1 (IL-1) is constitutively expressed by keratinocytes in vivo and has been shown to be expressed in psoriatic lesional skin. To determine what role the IL-1 system might contribute to the inflammatory process in psoriasis, semi-quantitative RT-PCR and cRNA microarray studies were performed on biopsies excised from lesional and non-lesional skin. Whilst IL-1 alpha mRNA levels showed a reduction in lesional skin in a subset of patients, steady state IL-1 beta mRNA was increased markedly. Neither of the two IL-1 receptor transcripts nor total IL-1 receptor antagonist exhibited major changes within the lesion. Expression of the IL-1-induced chemokine IL-8 was only observed in lesional epidermis. Functional genomic experiments comparing transcriptome profiles derived from psoriatic lesional skin and IL-1 stimulated keratinocytes demonstrated a striking level of overlap. Taken together, these data suggest that IL-1 is likely to be an important mediator in the initiation and maintenance of psoriatic plaques and may represent an attractive therapeutic target. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:72 / 78
页数:7
相关论文
共 50 条
  • [1] Interleukin-1β Is a Key Biomarker and Mediator of Inflammatory Vascular Calcification
    Shobeiri, Navid
    Bendeck, Michelle P.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (02) : 179 - 180
  • [2] EVOLUTIONARY CONSERVATION OF INTERLEUKIN-1 - AN INFLAMMATORY MEDIATOR
    BECK, G
    HABICHT, GS
    LYMPHOKINE RESEARCH, 1987, 6 (01): : U73 - U73
  • [3] Beyond an inflammatory mediator: Interleukin-1 in neurophysiology
    Lima, Tatiane S.
    EXPERIMENTAL PHYSIOLOGY, 2023, 108 (07) : 917 - 924
  • [4] Interleukin-1 as a Key Factor in the Development of Inflammatory Diseases
    Farivar, Shirin
    Hassani, Mandieh
    Shiari, Reza
    ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2014, 2 (04):
  • [5] Salivary interleukin-1: Oral inflammatory biomarker in patients with psoriasis
    Ganzetti, Giulia
    Campanati, Anna
    Santarelli, Andrea
    Sartini, Davide
    Molinelli, Elisa
    Brisigotti, Valerio
    Di Ruscio, Giulia
    Bobyr, Ivan
    Emanuelli, Monica
    Offidani, Annamaria
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2016, 44 : 10 - 14
  • [6] PSORIASIS AND INTERLEUKIN-1 - A TRANSLATION
    CORK, MJ
    TARLOW, JK
    BLAKEMORE, AIF
    MEE, JB
    CRANE, AM
    STIERLE, C
    BLEEHEN, SS
    DUFF, GW
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON, 1993, 27 (04): : 366 - 366
  • [7] INTERLEUKIN-1 AND INTERLEUKIN-6 IN PSORIASIS
    PRENS, EP
    BENNE, K
    VANDAMME, J
    BAKKUS, M
    BRAKEL, K
    BENNER, R
    VANJOOST, T
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 95 (06) : S121 - S124
  • [8] Interleukin-1β as a mediator of tubulointerstitial fibrosis
    Burns, KD
    KIDNEY INTERNATIONAL, 2002, 62 (01) : 346 - 347
  • [9] INTERLEUKIN-1 - AN IMPORTANT MEDIATOR OF INFLAMMATION
    DINARELLO, CA
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1984, 5 (10) : 420 - 422
  • [10] INTERLEUKIN-1 - A MEDIATOR WITH MULTIPLE FUNCTIONS
    CAVAILLON, JM
    HAEFFNERCAVAILLON, N
    PRESSE MEDICALE, 1986, 15 (05): : 185 - 187